pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,561
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
WSD-0922
Non-Small Cell Lung Cancer
Wayshine Biopharma Inc
0
catalysts
Phase 2
WTX-330
Colorectal Cancer
$HOWL
Werewolf Therapeutics, Inc.
0
catalysts
Phase 2
WVE-007
Obesity
$WVE
Wave Life Sciences Ltd.
0
catalysts
Phase 2
WVEN-531
Duchenne Muscular Dystrophy
← prev
page 31 of 53
next →
131
Pain
89
Neurology
1
$WVE
Wave Life Sciences Ltd.
0
catalysts
Phase 2
Wiskott-Aldrich Syndrome
Wiskott-Aldrich Syndrome
Thrombopoietin receptor
Genethon SA
0
catalysts
Phase 2
XRX-101
oxypurinol
Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury
Xanthine dehydrogenase/oxidase
$XRTX
XORTX Therapeutics Inc.
0
catalysts
Phase 2
XmAb bispecific antibody
Unspecified Cancer
$NVS
NOVARTIS AG
0
catalysts
Phase 2
YA-101
Multiple System Atrophy (Multi-System Degeneration)
Yoda Pharmaceuticals Inc
0
catalysts
Phase 2
YG-1699
Type 1 Diabetes (Juvenile Diabetes)
Youngene Therapeutics Co Ltd
0
catalysts
Phase 2
YH-12852
Diabetic Gastroparesis
$PCSA
Processa Pharmaceuticals, Inc.
0
catalysts
Phase 2
YH-42946
Non-Small Cell Lung Cancer
Yuhan Corp
0
catalysts
Phase 2
YL-13027
Solid Tumor
Shanghai Yingli Pharmaceutical Co Ltd
0
catalysts
Phase 2
YL-15293
Colorectal Cancer
Shanghai Yingli Pharmaceutical Co Ltd
0
catalysts
Phase 2
YPP-10
Keratoconjunctivitis Sicca (Dry Eye)
Yuyu Pharma Inc
0
catalysts
Phase 2
YR-001
Atopic Dermatitis (Atopic Eczema)
YIRUI Pharmaceutical Technology Co Ltd
0
catalysts
Phase 2
ZEN-3694
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Zenith Epigenetics Ltd
0
catalysts
Phase 2
ZEP-3
Herpes Labialis (Oral Herpes)
Shulov Innovative Science Ltd
0
catalysts
Phase 2
ZT-01
Nocturnal Hypoglycemia
Zucara Therapeutics Inc
0
catalysts
Phase 2
abefolastat tesaroxetan
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Clarity Pharmaceuticals Ltd
0
catalysts
Phase 2
abequolixron zinc
Epithelial Ovarian Cancer
Inspirna Inc
0
catalysts
Phase 2
acimtamig
acimtamig [INN]
Anaplastic Large Cell Lymphoma (ALCL)
Affimed GmbH
0
catalysts
Phase 2
actinium (225Ac) lintuzumab satetraxetan
Actimab A (actinium (225Ac) lintuzumab satetraxetan [INN])
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$ATNM
Actinium Pharmaceuticals, Inc.
0
catalysts
Phase 2
adrixetinib
adrixetinib [INN]
Solid Tumor
Qurient Co Ltd
0
catalysts
Phase 2
adrulipase alfa
adrulipase alfa [INN]
Exocrine Pancreatic Insufficiency
$GRDX
GridAI Technologies Corp.
0
catalysts
Phase 2
afamitresgene autoleucel
Tecelra (afamitresgene autoleucel)
Myxoid Liposarcoma
Melanoma-associated antigen 4
US WorldMeds LLC
0
catalysts
Phase 2
afimetoran
Systemic Lupus Erythematosus
Toll-like receptor 7
Toll-like receptor 8
Beeline Medicines Corp
0
catalysts
Phase 2
agomelatine
agomelatine [INN]
Major Depressive Disorder
$ANRO
Alto Neuroscience, Inc.
0
catalysts
Phase 2
aguracingene cadoparvovec
Achromatopsia
$MGTX
MeiraGTx Holdings plc
0
catalysts
Phase 2
albuvirtide LA
Human Immunodeficiency Virus (HIV) Infections (AIDS)
GP41
Frontier Biotechnologies Inc
0
catalysts
Phase 2
aleniglipron l-arginine
Overweight
$GPCR
Structure Therapeutics Inc.
0
catalysts
